LISATA THERAPEUTICS INC (LSTA) Forecast, Price Target & Analyst Ratings

NASDAQ:LSTAUS1280583022

Current stock price

5.01 USD
-0.02 (-0.4%)
At close:
5.05 USD
+0.04 (+0.8%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LISATA THERAPEUTICS INC (LSTA).

Forecast Snapshot

Consensus Price Target

Price Target
$11.56
+ 130.74% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.52
Revenue Estimate

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.56
Upside
+ 130.74%
From current price of $5.01 to mean target of $11.56, Based on 9 analyst forecasts
Low
$4.04
Median
$15.30
High
$15.75

Price Target Revisions

1 Month
19.30%
3 Months
-12.82%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for LSTA. The average price target is 11.56 USD. This implies a price increase of 130.74% is expected in the next year compared to the current price of 5.01.
The average price target has been revised downward by 12.82% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

LSTA Current Analyst RatingLSTA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

LSTA Historical Analyst RatingsLSTA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
LSTA was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LSTA.
In the previous month the buy percentage consensus was at a similar level.
LSTA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-21Brookline CapitalDowngrade Buy -> Hold
2025-08-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-15Brookline CapitalMaintains Buy -> Buy
2024-12-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-18HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-19HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-26HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-25HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-01HC Wainwright & Co.Reiterate Buy -> Buy
2024-01-04HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-25HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-31HC Wainwright & Co.Reiterate Buy
2022-10-19HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.52
Revenue Estimate
Revenue Q2Q
-100.00%
EPS Q2Q
5.42%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

LSTA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
LSTA revenue by date.LSTA revenue by date.
1M
-100.00%
10.2M7.344M
-28.00%
46.92M
538.89%
132.6M
182.61%
249.9M
88.46%
EBITDA
YoY % growth
LSTA ebitda by date.LSTA ebitda by date.
-57.53M
-98.45%
-25.519M
55.64%
-22.235M
12.87%
-26.01M
-16.98%
-29.784M
-14.51%
-34.272M
-15.07%
-26.418M
22.92%
N/AN/AN/A
EBIT
YoY % growth
LSTA ebit by date.LSTA ebit by date.
-57.6M
-98.28%
-25.708M
55.37%
-22.409M
12.83%
-23.118M
-3.16%
-29.58M
-27.95%
-43.35M
-46.55%
-43.809M
-1.06%
-43.86M
-0.12%
-29.58M
32.56%
111.18M
475.86%
Operating Margin
LSTA operating margin by date.LSTA operating margin by date.
N/AN/A-2,240.90%N/AN/A-425.00%-596.53%-93.48%-22.31%44.49%
EPS
YoY % growth
LSTA eps by date.LSTA eps by date.
-11.34
-45.38%
-2.58
77.25%
-2.40
6.98%
-2.37
1.19%
-0.98
58.71%
-0.67
31.25%
-1.00
-48.48%
N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth
-0.52
5.42%
Revenue
Q2Q % growth

-100.00%
EBITDA
Q2Q % growth
-7.14M
-49.53%
EBIT
Q2Q % growth
-4.896M
1.07%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LSTA Yearly Revenue VS EstimatesLSTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2022 2024 2027 2028 2029 2030 2031 50M 100M 150M 200M
LSTA Yearly EPS VS EstimatesLSTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -50 -100 -150 -200

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.80%
EPS Next 5 Year
12.18%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-10.73%
EBIT Next 5 Year
-1.14%

LISATA THERAPEUTICS INC / LSTA Forecast FAQ

What is the average price target for LISATA THERAPEUTICS INC (LSTA) stock?

9 analysts have analysed LSTA and the average price target is 11.56 USD. This implies a price increase of 130.74% is expected in the next year compared to the current price of 5.01.

What is the next earnings date for LSTA stock?

LISATA THERAPEUTICS INC (LSTA) will report earnings on 2026-05-06.

What are the consensus estimates for LISATA THERAPEUTICS INC (LSTA) next earnings?

The consensus EPS estimate for the next earnings of LISATA THERAPEUTICS INC (LSTA) is -0.52 USD and the consensus revenue estimate is 0 USD.